kaleorid lp 600mg toimeainet prolongeeritult vabastav tablett
leo pharma a/s - kaaliumkloriid - toimeainet prolongeeritult vabastav tablett - 600mg 30tk
kalinor-retard p toimeainet prolongeeritult vabastav kõvakapsel
itc farma srl - kaaliumkloriid - toimeainet prolongeeritult vabastav kõvakapsel - 600mg 100tk
sando-k kihisev tablett
elara pharmaservices limited - kaaliumkloriid+kaaliumvesinikkarbonaat - kihisev tablett - 600mg+400mg 100tk
low-k õhukese polümeerikattega tablett
redson pharmaceuticals - kaaliumkloriid - õhukese polümeerikattega tablett - 600mg 100tk
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic kasvajad, kastreerimine-vastupidavad - antineoplastilised ained - treatment of adult patients with prostate cancer.
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - kõik muud ravitoimingud - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
chlorpot infusioonilahuse kontsentraat
brooks laboratories limited - kaaliumkloriid - infusioonilahuse kontsentraat - 150mg 1ml 10ml 5tk
orserdu
stemline therapeutics b.v. - elacestrant - rinnanäärmed - endokriinset ravi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
aqumeldi
proveca pharma limited - enalapril (maleate) - südamepuudulikkus - reniini-angiotensiini süsteemi toimivad ained - treatment of heart failure.
losartan/hydrochlorothiazide ipca õhukese polümeerikattega tablett
ipca produtos farmaceuticos unipessoal lda - losartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 50mg+12,5mg 98tk; 50mg+12,5mg 14tk; 50mg+12,5mg 56tk; 50mg+12,5mg 28tk